Nuclera’s Key Account Manager shares how their eProtein Discovery system is propelling rapid recombinant protein optimization and its utilization in drug discovery.

From the original plasmid for MBP-CdvB2, the whole plasmid except for the C-terminus of the protein was copied by PCR. The resulting linearized plasmid was checked on an agarose gel, and then treated ...